Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Market Edge
|
$10.00
|
|
Provider: S&P Capital IQ – STARS Reports
|
$115.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Intuitive Surgical Issues Q3 2012 Revenue Guidance In Line With Analysts' Estimates; Raises FY 2012 Revenue Guidance-Conference Call
Intuitive Surgical announced that for third quarter of 2012, it expects revenue to be near or possibly below second quarter 2012 level. For fiscal 2012, it expects revenue to grow 20%-23% above total 2011 revenue of $1.76 billion. The Company reported revenue of $536.50 million in second quarter of 2012. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $531 million for third quarter of 2012 and revenue of $2.135 billion for fiscal 2012.
Latest Developments for Intuitive Surgical Inc
- Intuitive Surgical Inc Sees FY 2013 Revenue Guidance Towards Higher End Of Prior Range-Conference Call
- Intuitive Surgical Inc Sees FY 2013 Revenue Guidance At High End Of Prior Range; Comments On FY 2013 Operating Income Guidance-Conference Call
- Intuitive Surgical Inc Announces Increase in Share Repurchase Program
- Intuitive Surgical Inc Reaffirms FY 2013 Revenue Guidance-Conference Call
Latest Key Developments in Advanced
- Edap Tms SA Receives CE Mark For Focal.one
- Andor Technology plc Issues FY 2013 Revenue Guidance Below Analysts' Estimates-DJ
- Boston Scientific Corp's Vercise DBS System Demonstrates Improvement In Motor Function For Patients With Parkinson's Disease
- USCOM Ltd Completes Pulsecor Asset Purchase and Acquires New BP+ Central Blood Pressure Device
- Share this
- Link this
- Digg this
Follow Reuters